Class I
Ongoing
Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1
This recall is currently active, issued October 22, 2025. It was issued by Integradose Compounding Services Llc.
- Recall Initiated
- September 16, 2025
- Posted
- October 22, 2025
- Recall Number
- D-0015-2026
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 853/500 mL bags
- Firm Location
- Minneapolis, MN, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
Distribution
Nationwide in the USA
Lot / Code Info
Lot #: 20250620OXY-1, Expiration date 10/18/2025
More recalls by Integradose Compounding Services Llc
fentaNYL Citrate 2,500 mcg/50mL in Sterile Water, 50 mL CADD for Injection, IntegraDose Compounding...
Apr 10, 2024 · Class II
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Uni...
Feb 21, 2024 · Class II
Other recent Class I Drug recalls
UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactu...
Mckesson
· Feb 18, 2026
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLu...
Green Lumber Holdings, Llc
· Feb 11, 2026
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India...
Handelnine Global Llc
· Feb 11, 2026
ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNat...
Medinatura New Mexico, Inc.
· Jan 14, 2026
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, L...
Fresenius Kabi Usa, Llc
· Dec 3, 2025